Ultrasound Guided Versus Surgical Rectus Sheath Block Versus Local Anesthesia Infiltration for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy
- Conditions
- UltrasoundRectus Sheath BlockSurgicalLocal Anesthesia InfiltrationPostoperative AnalgesiaTotal Abdominal Hysterectomy
- Interventions
- Drug: Ultrasound-guided rectus sheath blockDrug: Surgical rectus sheath blockDrug: Local anesthesia infiltration
- Registration Number
- NCT06837532
- Lead Sponsor
- Ain Shams University
- Brief Summary
The aim of this work is to compare the efficacy and safety of the effectiveness and safety of ultrasound-guided surgical rectus sheath block and local anesthetic infiltration for postoperative analgesia in patients undergoing total abdominal hysterectomy.
- Detailed Description
Total abdominal hysterectomy (TAH) is a commonly performed major surgical procedure that results in substantial postoperative pain and discomfort.
Local anesthetic infiltration (LAI) at the end of surgery is one of the most common technique employed in laparotomies for postoperative analgesia.
Rectus sheath block (RSB) has been used as a part of multimodal analgesia, especially when neuraxial techniques are unsuitable.The RSB was used to achieve peri-operative relaxation of the anterior abdominal wall.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 90
- Age from 18 to 65 years old.
- American Society of Anesthesiologists (ASA) physical status I - II.
- Patients scheduled for elective total abdominal hysterectomy under general anesthesia.
- Hepatic, renal or cardiac disease.
- Any known allergy to local anesthetic.
- Physical or mental conditions which may vaguely measure postoperative pain following surgery.
- History of chronic use of analgesic as nonsteroidal anti-inflammatory drugs (NSAIDs) or central nervous system (CNS) depressants as antiepileptic, and bleeding disorders.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ultrasound-guided rectus sheath block group Ultrasound-guided rectus sheath block Patients will receive ultrasound-guided rectus sheath block (20 ml bupivacaine 0.25%) bilaterally at the end of surgery. Surgical rectus sheath block group Surgical rectus sheath block Patients will receive a surgical rectus sheath block (20 ml bupivacaine 0.25%) bilaterally at the time of closure. Local anesthesia infiltration group Local anesthesia infiltration Patients will receive local anesthesia infiltration at the end of surgery.
- Primary Outcome Measures
Name Time Method Total morphine consumption 24 hours postoperatively Rescue analgesia of morphine will be given as 3 mg bolus if the Visual Analogue Scale (VAS)\> 3 to be repeated after 30 min if pain persists until the VAS \< 4.
- Secondary Outcome Measures
Name Time Method Heart rate Till the end of surgery (Up to 4 hours) Heart rate will be recorded preoperatively, before the block is performed, and every 15 minutes until the end of the surgery.
Mean arterial pressure Till the end of surgery (Up to 4 hours) Mean arterial pressure will be recorded preoperative, before performing of block, and every 15 min till the end of surgery.
Time to the first request for the rescue analgesia 24 hours postoperatively Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administrated).
Degree of pain 24 hours postoperatively Each patient will be instructed about postoperative pain assessment with the Visual Analogue Scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed at PACU, 2, 4, 6, 12, 18, and 24h postoperatively.
Degree of patient satisfaction 24 hours postoperatively Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied).
Incidence of adverse events 24 hours postoperatively Incidence of adverse events such as hematoma, nerve damage or neuropathy, bradycardia, hypotension, nausea, vomiting, pruritis, urinary retention, or any other complication will be recorded.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ain Shams University
🇪🇬Cairo, Egypt
Ain Shams University🇪🇬Cairo, EgyptSarah A Afifi, MDContact0501035864Sarah606060@gmail.comSondos Afifi, MDPrincipal InvestigatorAhmed Eldemerdash, MDPrincipal Investigator